Page 2,118«..1020..2,1172,1182,1192,120..2,1302,140..»

Stem cell progeny tell their parents when to turn on

Posted: May 10, 2014 at 4:51 am

22 hours ago A signal from Transit-Amplifying Cells (TACs) activates stem cells in the hair follicle, researchers have found. Both types of cells appear in green (top), with TACs clustered lower down. The researchers identified the signal as Sonic Hedgehog. In experiments, such as this one (bottom), they disabled the signal, interfering with hair growth and regeneration.

(Phys.org) Stem cells switch off and on, sometimes dividing to produce progeny cells and sometimes resting. But scientists don't fully understand what causes the cells to toggle between active and quiet states.

New research in Elaine Fuchs' Laboratory of Mammalian Cell Biology and Development focused on stem cells in the hair follicle to determine what switches them on. The researchers found cells produced by the stem cells, progeny known at Transit-Amplifying Cells or TACs, emit a signal that tells quiet hair follicle stem cells to become active.

"Many types of mammalian stem cells produce TACs, which act as an intermediate between the stem cells and their final product: fully differentiated cells in blood, skin and elsewhere," says Ya-Chieh Hsu, who conducted the research while as a postdoc in the lab and will soon move to Harvard University. "In the past, TACs were seen as a population of cells that sat by passively cranking out tissues. No one expected them to play a regulatory role."

Hsu and Fuchs went a step further to identify the signal sent out by the TACs. They pinpointed a cell-division promoting protein called Sonic Hedgehog, which plays a role in the embryonic development of the brain, eyes and limbs.

Stem cells are medically valuable because they have the potential to produce a number of specialized cells suitable for specific roles. Stem cells' production of these differentiated cells is crucial to normal maintenance, growth and repair. Many tissues have two populations of stem cells: one that divides rarely, known as the quiescent stem cells, and another that is more prone to proliferate, known as primed stem cells. Regardless of their proliferation frequency, most stem cells in humans do not directly produce differentiated progeny cells; instead, they give rise to an intermediate proliferating population, the TACs.

The hair follicle, the tiny organ that produces a hair, forms a narrow cavity down into the skin. It cycles between rounds of growth, destruction and rest. When entering the growth phase, the primed stem cell population is always the first to divide and generates the TACs clustered lower down in the hair follicle. Primed stem cell proliferation sets the stage for the next round of hair growth, a process which ensures hairs are replaced as they are lost over time. Proliferating TACs produce the hair shaft, as well as all the cells surrounding the hair underneath the skin, which make up the follicle itself.

At the outset, Hsu and Fuchs suspected a role for both the TACs and for Sonic Hedgehog in hair regeneration.

"We noticed that the primed stem cell population gets activated early and makes the TACs, while the quiescent stem cell population only becomes activated once TACs are generated. This correlation prompted us to look for a signal that is made by the TACs. Sonic Hedgehog is that signal, as we went on to demonstrate," explained Fuchs.

In experiments described this week in Cell, Hsu disabled TACs' ability to produce the Sonic Hedgehog protein by knocking out the gene responsible in the hair follicles of adult mice. As a result, the proliferation of hair follicle stem cells and their TACs are both compromised. They further showed that it is the quiescent stem cell population which requires Sonic Hedgehog directly for proliferation.

Here is the original post:
Stem cell progeny tell their parents when to turn on

Posted in Stem Cells | Comments Off on Stem cell progeny tell their parents when to turn on

New Vet-Stem Patent for Stem Cells Covers Sports Medicine Applications

Posted: May 10, 2014 at 4:51 am

Poway, California (PRWEB) May 08, 2014

Vet-Stem, Inc., announced that a major patent has been issued directly to Vet-Stem for New Zealand. This patent covers methods for extracting/preparing and using adipose tissue-derived stem cells for preventing or treating diseases in any mammal, including humans. This patent will provide coverage for the ongoing commercial and development programs at Vet-Stem and for its licensees in Australasia. This patent may be available for licensing for human applications to other companies interested in working in this field.

Of particular interest is the application to the rapidly evolving field of Regenerative Sports Medicine. This patent covers the preparation methods and use of adipose-derived stem cells in treating any type of disease, but specifically covers the use in injuries or diseases of the musculoskeletal system such as tendon tears, ligament injury and osteoarthritis.

This new patent issued to Vet-Stem adds to the many other patents in the Vet-Stem portfolio that cover methods of preparing and using regenerative cells from adipose. Vet-Stem has already had a similar patent issue in the EU and applications are pending in the US and other countries. In addition to these owned patents, Vet-Stem has exclusive worldwide rights to a portfolio of patents (over 50 issued and 70 pending patents) from Artecel, Inc. (including University of Pittsburgh patents) and the University of California, which further strengthens the companys intellectual property position in this rapidly developing field.

As the first company in the world to offer fat derived stem cell services for veterinary use, Vet-Stem has rapidly developed the market, providing treatments to over 10,000 horses, dogs, cat and exotic species. Intellectual property rights can be confusing in a rapidly developing market with evolving technology, said Bob Harman, DVM, MPVM, CEO of Vet-Stem. We needed to do everything possible to protect the market that we are creating in regenerative veterinary medicine and to ensure that the value of the company is optimized. The value of this technology has increased greatly since the founding of the company in 2002 as the business model, therapeutic activity of the cells, and ease of tissue collection have all been demonstrated.

About Vet-Stem, Inc. Vet-Stem, Inc. was formed in 2002 to bring regenerative medicine to the veterinary profession. The privately held company is working to develop therapies in veterinary medicine that apply regenerative technologies while utilizing the natural healing properties inherent in all animals. As the first company in the United States to provide an adipose-derived stem cell service to veterinarians for their patients, Vet-Stem, Inc. pioneered the use of regenerative stem cells in veterinary medicine. The company holds exclusive licenses to over 50 patents including world-wide veterinary rights for use of adipose derived stem cells. In the last decade over 10,000 animals have been treated using Vet-Stem, Inc.s services, and Vet-Stem is actively investigating stem cell therapy for immune-mediated and inflammatory disease, as well as organ disease and failure. For more on Vet-Stem, Inc. and Veterinary Regenerative Medicine visit http://www.vet-stem.com or call 858-748-2004.

Read the original post:
New Vet-Stem Patent for Stem Cells Covers Sports Medicine Applications

Posted in Stem Cells | Comments Off on New Vet-Stem Patent for Stem Cells Covers Sports Medicine Applications

Production of synthetic SIRT1 as a dietary supplement may help prolong life, states Chemist Direct

Posted: May 10, 2014 at 4:44 am

(PRWEB UK) 9 May 2014

Over the course of the human life span the body ages and becomes less able to repair itself, allowing it to become more prone to disease and illness. In the ever developing field of scientific discovery researchers have become intrigued with the concept of finding a way to slow down age-related diseases and prolonging life through the use of medicine. Since the Japanese scientist Shinya Yamanaka (http://bit.ly/1kWb20u) first discovered iPS cells in adult tissue and pioneered mature cell regeneration, this field in medicine has become one of the most rapidly developing fields in biomedicine.

A research team at the National Institute on Ageing at the National Institutes of Health in the US has discovered a promising strategy to arrest ageing by looking at a chemical called SRT1720 which activates a particular protein called Sirtuin 1 (SIRT1). Previous research has demonstrated that activating SIRT1 can have health benefits in various organisms, and it has been proposed as an anti-ageing protein. This study, published in the March edition of Research Journal: Cell (http://bit.ly/1od2gS5) focused on comparing the lifespan, health and diseases of mice fed the same diet, but with or without the addition of a SRT1720.

Overall they found mice fed a normal diet but with the supplement had a longer natural lifespan on average (about five weeks longer). During their lifetime, additional tests also suggested they had improved muscle function and coordination, improved metabolism, improved glucose tolerance, decreased body fat and cholesterol. All in all this suggests that giving the mice this supplement could protect them from the equivalent of metabolic syndrome, a series of risk factors associated with conditions such as heart disease and type 2 diabetes.

A study published today in the journal Stem Cell Reports (http://bit.ly/1hBSDF6) and carried out by the Spanish National Cancer Research Centre's Telomeres and Telomerase Group, reveals that the SIRT1 protein is needed to lengthen and maintain telomeres during cell reprogramming. SIRT1 also guarantees the integrity of the genome of stem cells that come out of the cell reprogramming process; these cells are known as iPS cells (induced Pluripotent Stem cells).

The nature of iPS cells, however, is causing intense debate. The latest research shows that chromosome aberrations and DNA damage can accumulate in these cells. "The problem is that we don't know if these cells are really safe," says Mara Luigia De Bonis, a postdoctoral researcher who has done a large part of the work. http://bit.ly/1m5gRgb

Researchers did not look at whether SIRT1 may cause side effects or complications so it is currently unclear whether SIRT1 would be safe in humans, let alone effective, but this interesting research has opened doors to pharmaceutical companies to develop dietary supplements that can help provide anti-aging pills, especially those who suffer hereditary degenerative diseases. These ongoing scientific studies will help shed light on how cell reprogramming guarantees the healthy functioning of stem cells. This knowledge will help to overcome barriers that come out of the use of iPS cells so they may be used in regenerative medicine.

Excerpt from:
Production of synthetic SIRT1 as a dietary supplement may help prolong life, states Chemist Direct

Posted in Cell Medicine | Comments Off on Production of synthetic SIRT1 as a dietary supplement may help prolong life, states Chemist Direct

Acute torn meniscus; 5 months after stem cell therapy by Dr Harry Adelson – Video

Posted: May 10, 2014 at 4:43 am


Acute torn meniscus; 5 months after stem cell therapy by Dr Harry Adelson
At Docere Clinics, the vast majority of cases we see are for chronic pain. Occasionally, we get acute injuries and do very well with them. Here, Bryan describes his experience 5 months after...

By: Harry Adelson, N.D.

Originally posted here:
Acute torn meniscus; 5 months after stem cell therapy by Dr Harry Adelson - Video

Posted in Cell Therapy, Stem Cell Therapy | Comments Off on Acute torn meniscus; 5 months after stem cell therapy by Dr Harry Adelson – Video

Treating Knee Osteoarthritis with Stem Cells – Dr. Ben Newton | Regenexx – Video

Posted: May 10, 2014 at 4:43 am


Treating Knee Osteoarthritis with Stem Cells - Dr. Ben Newton | Regenexx
Dr. Ben Newton discusses knee osteoarthritis and the use of stem cells for treating this common condition and avoiding knee replacement surgery. Regenexx off...

By: Regenexx

View post:
Treating Knee Osteoarthritis with Stem Cells - Dr. Ben Newton | Regenexx - Video

Posted in Stem Cell Videos | Comments Off on Treating Knee Osteoarthritis with Stem Cells – Dr. Ben Newton | Regenexx – Video

How Stem Cells Decide Who to Be by Christina Jones – Video

Posted: May 10, 2014 at 4:43 am


How Stem Cells Decide Who to Be by Christina Jones
Part of the UW #39;s Engage Program, Christina Jones presented her PhD work on How Stem Cells Decide Who to Be. This talk was presented at Town Hall Seattle as part of the UW Science Now lecture...

By: Engage Science

Read the original:
How Stem Cells Decide Who to Be by Christina Jones - Video

Posted in Stem Cell Videos | Comments Off on How Stem Cells Decide Who to Be by Christina Jones – Video

Mass. Scientists Develop Trachea Out Of Plastic, Stem Cells – Video

Posted: May 10, 2014 at 4:42 am


Mass. Scientists Develop Trachea Out Of Plastic, Stem Cells
The same technology is being used to build an artificial esophagus. WBZ-TV #39;s Dr. Mallika Marshall reports. Read more recent News stories: http://cbsboston.co...

By: CBS Boston

See the article here:
Mass. Scientists Develop Trachea Out Of Plastic, Stem Cells - Video

Posted in Stem Cell Videos | Comments Off on Mass. Scientists Develop Trachea Out Of Plastic, Stem Cells – Video

Man believed to be offering stem-cell therapy without a license – Video

Posted: May 10, 2014 at 4:42 am


Man believed to be offering stem-cell therapy without a license
Undercover agents arrested a man claiming to be a doctor who was providing stem-cell treatments for injured athletes. Authorities say the man has no medical professional licenses.

By: WPBF 25 News

View original post here:
Man believed to be offering stem-cell therapy without a license - Video

Posted in Stem Cell Treatments | Comments Off on Man believed to be offering stem-cell therapy without a license – Video

Stem Cell Research for Heart and Vascular Diseases – Video

Posted: May 10, 2014 at 4:42 am


Stem Cell Research for Heart and Vascular Diseases

By: rushmedicalcenter

Read the original:
Stem Cell Research for Heart and Vascular Diseases - Video

Posted in Stem Cell Research | Comments Off on Stem Cell Research for Heart and Vascular Diseases – Video

ENG 1020 Stem Cell Research Project New – Video

Posted: May 10, 2014 at 4:42 am


ENG 1020 Stem Cell Research Project New

By: n lon

View post:
ENG 1020 Stem Cell Research Project New - Video

Posted in Stem Cell Research | Comments Off on ENG 1020 Stem Cell Research Project New – Video

Page 2,118«..1020..2,1172,1182,1192,120..2,1302,140..»